News Agency
The Times Real Estate

Asieris Pharmaceuticals Releases 2024 Annual Report, with Revenue Exceeding RMB 200M in 1st Year of Commercialization and Innovative Portfolio Accelerating Toward Launch

  • Written by PR Newswire

SHANGHAI, April 18, 2025 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2024 Annual Report, highlighting a bold and determined journey forward. With a specialty pharma strategy and operational efficiency, the company exceeded its commercialization targets and advanced its innovative products — APL-1702 and APL-1706 (Hexvix®)...

Read more: Asieris Pharmaceuticals Releases 2024 Annual Report, with Revenue Exceeding RMB 200M in 1st Year...

Overcoming Dental Anxiety: A Guide to Comfortable Implant Procedures in Perth

Dental anxiety is a prevalent issue that keeps numerous patients away from their much-needed oral care treatment. This anxiety can be more extreme in the case of more involved procedures like dental implants. Nevertheless, due to advances in modern dentistry... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion